SEC Form 4 · accession 0001053369-15-000001
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nasrat A Hakim
Officer — President & CEO · Director · 10% Owner
Period of report
Mar 5, 2015
Accepted (ET)
Mar 9, 2015 · 2:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common | Mar 5, 2015 | A | 2,046,554 | $0.342 | A | 13,760,695 | D | |
| common | holding | — | — | — | 2,700,000 | I | by IRA |
Table II — derivative securities
No Table II lines on this filing.